Q. What is aqueductal stenosis?

Aqueductal stenosis refers to narrowing or complete obstruction of the cerebral aqueduct (aqueduct of Sylvius), resulting in impaired cerebrospinal fluid flow from the third to the fourth ventricle. This leads to triventricular hydrocephalus, characterized by dilation of both lateral ventricles and the third ventricle with a normal-sized fourth ventricle. It is one of the most common causes of congenital obstructive hydrocephalus, accounting for up to 70 percent of congenital hydrocephalus.

​

Q. What are the key radiological features of aqueductal stenosis?

​

MRI (Gold standard):

• Triventricular hydrocephalus with dilation of the lateral and third ventricles

• Normal-sized fourth ventricle

• Loss of the normal aqueductal T2 flow void

• Tectal plate beaking, in which the superior colliculi are displaced anteriorly and inferiorly by the enlarged third ventricle, supporting a mechanical obstructive process

• Bowing of the third ventricular floor

• Widening of the third ventricle on sagittal images

​

Normally, rapid pulsatile CSF flow within the aqueduct produces a signal dropout on T2-weighted images due to flow-related dephasing. In aqueductal stenosis, CSF flow is reduced or absent, abolishing this effect and causing the aqueduct to appear hyperintense on T2-weighted sequences.

• Post-contrast MRI is essential to exclude:

  • Tectal plate glioma

  • Brainstem tumor infiltration

  • Quadrigeminal cistern arachnoid cyst

Cine MRI (when available):

• Absence of pulsatile CSF flow through the aqueduct

• Useful for confirming functional obstruction when structural narrowing is subtle

​

CT scan:

• Demonstrates triventricular hydrocephalus

• Fourth ventricle remains normal in size

• Useful in emergency settings

• Limited sensitivity for thin aqueductal membranes or webs

 

Cranial ultrasound (infants):

• Dilation of lateral and third ventricles visualized through the open anterior fontanelle

• Useful as a screening tool in neonates and young infants

​

Q. What are the etiologies of aqueductal stenosis?

Aqueductal stenosis may be congenital or acquired.

Congenital etiologies include isolated developmental narrowing of the aqueduct or association with other congenital anomalies such as Chiari malformation and neurofibromatosis.

 

A severe inherited form is X-linked aqueductal stenosis due to L1CAM mutation, which predominantly affects males and often presents early with severe obstructive hydrocephalus. Characteristic associated features include:

• Adducted thumbs

• Spasticity

• Agenesis or hypoplasia of the corpus callosum

 

Neurodevelopmental outcome is generally poorer compared with isolated congenital aqueductal stenosis. Identification is essential for genetic counseling, assessment of recurrence risk, and antenatal decision-making, as female carriers may be asymptomatic.

 

Acquired etiologies include:

• Post-inflammatory: meningitis, tuberculous meningitis, intrauterine infections

• Post-hemorrhagic: neonatal intraventricular hemorrhage, subarachnoid hemorrhage with adhesions

• Neoplastic: tectal plate gliomas, brainstem astrocytomas

• Cystic: quadrigeminal cistern arachnoid cyst compressing the aqueduct

• Others: lipoma involving the aqueduct

 

Q. How do you classify aqueductal stenosis?

​

Aqueductal stenosis is classically classified according to the Russell classification, which describes four pathological patterns:

• Forking: Replacement of the normal aqueduct by multiple narrow channels due to partial fusion of the median fissure. Channels may rejoin or end blindly. Often associated with spinal dysraphism such as spina bifida and lipomyelocele.

• Periaqueductal gliosis: Characterized by proliferation of astrocytes and subependymal glial fibers narrowing the lumen, which can be reactive (post-inflammatory/hemorrhagic) or pressure-induced.

• True stenosis: Uniform congenital narrowing resulting from abnormal neuroepithelial folding.

• Septum formation: Occlusion of the distal aqueduct by a glial membrane, producing complete obstruction.

 

Q. How do infants with aqueductal stenosis present?

​

Infants typically present with features of obstructive hydrocephalus, as open sutures permit skull expansion. Common features include:

• Progressive macrocephaly

• Bulging, tense fontanelle

• Sunsetting of the eyes due to dorsal midbrain compression

• Engorged scalp veins

• Irritability, vomiting, and poor feeding

• Delayed developmental milestones due to cortical mantle thinning

 

If untreated, long-term consequences include optic atrophy, seizures, and severe neurodevelopmental delay.

 

Q. What are the clinical features in older children?
 

After suture fusion, compensatory skull expansion is no longer possible and symptoms of raised intracranial pressure predominate:

• Persistent, often morning headaches

• Nausea and vomiting

• Papilledema

• Diplopia or blurred vision

• Gait imbalance

• Behavioral changes and cognitive slowing

• Decline in school performance

 

Q. How does aqueductal stenosis present in adults?
 

Adult aqueductal stenosis may present insidiously or acutely. Clinical features include:

• Chronic headaches

• Cognitive decline that may mimic normal-pressure hydrocephalus

• Magnetic gait and frequent falls

• Visual disturbance

• Urinary urgency or incontinence in advanced cases

 

Endocrine dysfunction related to hypothalamic-pituitary compression is uncommon but may occur. Some patients remain clinically compensated for years until a secondary insult precipitates sudden intracranial pressure elevation and rapid deterioration.

 

Q. What are the differential diagnoses of triventricular hydrocephalus?

​

Important differential diagnoses include:

• Colloid cyst of the foramen of Monro: Obstruction at the foramina with patent aqueduct

• Quadrigeminal cistern arachnoid cyst: External compression of the aqueduct

• Posterior fossa tumors: Medulloblastoma, ependymoma, cerebellar tumors

• Intraventricular tumors: Central neurocytoma, choroid plexus tumors

• Post-meningitic or post-hemorrhagic adhesions: Particularly in neonates

 

Q. How will you manage aqueductal stenosis?

​

Management aims to restore cerebrospinal fluid circulation, address the underlying cause when present, and prevent long-term neurological sequelae. Treatment choice depends on patient age, ventricular anatomy, etiology, and basal cisternal patency.

 

Endoscopic third ventriculostomy (ETV) is the preferred treatment for most patients, particularly older children and adults. It establishes an alternative CSF pathway between the third ventricle and the prepontine cistern. In appropriately selected patients, success rates range from 80 to 95 percent. Infants younger than six months have higher failure rates due to immature CSF absorption and poorly developed subarachnoid spaces.

 

Aqueductoplasty is reserved for selected cases with short-segment membranous obstruction, such as septa or thin glial membranes. It is most effective in distal congenital membranous stenosis and less successful in long-segment gliotic narrowing or infiltrative tumors.

 

Ventriculoperitoneal shunting is indicated when endoscopic procedures are unsuitable or have failed, particularly in:

• Infants younger than six months

• Multiloculated ventricles

• Extensive basal cisternal scarring

• Post-infectious or post-hemorrhagic obstruction

• Recurrent obstruction after endoscopic treatment

 

Programmable valves help reduce overdrainage-related complications.

 

Management of underlying pathology depends on etiology. Tectal plate gliomas are typically managed conservatively with CSF diversion alone. Arachnoid cysts may require cyst fenestration or ventriculo-cysto-cisternostomy. Tumoral posterior fossa obstruction requires tumor-directed therapy, with CSF diversion performed first if hydrocephalus is acute.

Lumbar puncture is contraindicated due to the risk of transtentorial or tonsillar herniation.

 

Q. What is the prognosis of aqueductal stenosis?

​

Prognosis depends on age at presentation, etiology, and duration of hydrocephalus. Early intervention in infancy improves neurodevelopmental outcomes by preventing prolonged cortical mantle thinning. Isolated congenital aqueductal stenosis carries an excellent long-term prognosis, whereas associated anomalies worsen outcome. Adults often experience symptom reversal if treated early, although chronic cases may have residual gait or cognitive deficits. Recurrence is uncommon when obstruction is appropriately managed.

 

Q. How do you diagnose aqueductal stenosis antenatally and what is the prenatal course?

​

Aqueductal stenosis may be suspected antenatally when routine obstetric ultrasound shows progressive ventriculomegaly, typically involving the lateral and third ventricles. Serial antenatal scans demonstrating increasing ventricular dilatation over gestation support an obstructive mechanism rather than communicating hydrocephalus. Fetal MRI helps confirm aqueductal obstruction, assess cortical mantle thickness, and identify associated anomalies such as agenesis of the corpus callosum, Chiari malformation, or syndromic features including those suggestive of L1CAM-related hydrocephalus. Prognosis is influenced by the degree and progression of ventriculomegaly, preservation of the cortical mantle, and presence of associated CNS or genetic abnormalities.

​

Q. What is the surgical anatomy and anatomical prerequisites for endoscopic third ventriculostomy (ETV)?

​

ETV success depends on correct third ventricular floor anatomy recognition and patency of basal cisterns. The optimal perforation site is the tuber cinereum, typically located anterior to the mammillary bodies and posterior to the infundibular recess, where the third ventricular floor is thinnest. A well-developed prepontine cistern is necessary to allow effective CSF egress after ventriculostomy. Preoperative and intraoperative awareness of the basilar artery and its perforators is essential to prevent catastrophic vascular injury. Unfavorable anatomy includes a thickened or opaque third ventricular floor and obliterated basal cisterns, both of which reduce the likelihood of durable ETV success.

 

Q. What are the failure patterns and clinical warning signs following ETV?

​

ETV failure may be early or late. Early failure usually occurs within days to weeks and presents with persistent or recurrent features of raised intracranial pressure due to inadequate stoma creation, insufficient opening into the prepontine cistern, or impaired CSF absorption. Late failure may occur months to years later, most commonly due to gradual stoma closure, and can present with recurrent headache, vomiting, papilledema, or rapid neurological deterioration. Recurrent headache is often the earliest warning symptom. Long-term follow-up is essential because delayed and sometimes abrupt decompensation can occur even after an initially successful ETV.